Menu
Recruiting NCT06611020

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Observational Cervical Intraepithelial Neoplasia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Cervical Intraepithelial Neoplasia. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia

Overview

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Detailed description

Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.

Primary outcome measures

  • HPV recurrence [Time frame: 2 years]

Eligibility criteria

Inclusion criteria

  • Treatment of HPV-related disease

Exclusion criteria

  • Previous HPV vaccination

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Italy · 2 centers
  • Fondazione IRCCS Istituto Nazionale dei Tumori — Milan
  • Fondazione IRCCS Istituto Nazionale dei Tumori — Milan

Publications

  • Caia C, De Maria F, Sopracordevole F, Ciavattini A, Casarin J, Ghezzi F, Vizzielli G, Chiappa V, Leone Roberti Maggiore U, Valsecchi C, Scambia G, Raspagliesi F, Corso G, Bogani G. Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia. Eur J Cancer Prev. 2026 May 1;35(3):243-249. doi: 10.1097/CEJ.0000000000000971. Epub 2025 Apr 18. PMID 40277212

Identifiers

NCT: NCT06611020 · 570/20

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗